Novonesis AS (OCSE:NSIS B) Accounts Payable : kr1,616 Mil (As of Dec. 2023)

View and export this data going back to 2000. Start your Free Trial

What is Novonesis AS Accounts Payable?

Novonesis AS's Accounts Payable for the quarter that ended in Dec. 2023 was kr1,616 Mil.

Novonesis AS's quarterly Accounts Payable increased from Jun. 2023 (kr1,321 Mil) to Sep. 2023 (kr1,460 Mil) and increased from Sep. 2023 (kr1,460 Mil) to Dec. 2023 (kr1,616 Mil).

Novonesis AS's annual Accounts Payable increased from Dec. 2021 (kr1,490 Mil) to Dec. 2022 (kr1,869 Mil) but then declined from Dec. 2022 (kr1,869 Mil) to Dec. 2023 (kr1,616 Mil).

Novonesis AS Accounts Payable Historical Data

The historical data trend for Novonesis AS's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Accounts Payable Chart

Novonesis AS Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

1,117.00

1,100.00

1,490.00

1,869.00

1,616.00

Novonesis AS Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Accounts Payable	Get a 7-Day Free Trial															1,869.00	1,452.00	1,321.00	1,460.00	1,616.00

Novonesis AS Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Novonesis AS Accounts Payable Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Novonesis AS (OCSE:NSIS B) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (OCSE:NSIS B) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

NVZMY:USA NVZMF:USA NZYM:Mexico NZYMBc:UK 0Q4U:UK NZM2:Germany

Address

Krogshoejvej 36, Bagsvaerd, DNK, 2880

Website

https://www.novozymes.com

Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (OCSE:NSIS B) Headlines

No Headlines